Michael L. Eagle is Director at Somaxon Pharmaceuticals, Inc. (SOMX). They have made 7 open-market trades across 2 companies since 2008, most recently 2016-07-27.
CIK 0001288237
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
4 open-market purchases totalling $96K since 2008, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HNSN | BUY | 2014-05-13 | 2014-05-14 | $1.20 | $12K | -17.9% | -2.0% | -2.0% |
| HNSN | BUY | 2014-03-11 | 2014-03-12 | $2.29 | $23K | -17.9% | -2.0% | -2.0% |
| HNSN | BUY | 2013-05-13 | 2013-05-15 | $1.66 | $10K | -17.9% | -2.0% | -2.0% |
| SOMX | SELL · 10b5-1 | 2010-12-01 | 2010-12-03 | $2.68 | $67K | N/A | N/A | N/A |
| FVRL | SELL | 2008-12-23 | 2008-12-24 | $0.03 | $114 | N/A | N/A | N/A |
| FVRL | SELL | 2008-12-03 | 2008-12-05 | $0.03 | $750 | N/A | N/A | N/A |
| FVRL | SELL | 2008-11-24 | 2008-11-25 | $0.29 | $7K | N/A | N/A | N/A |
| FVRL | BUY | 2008-02-27 | 2008-02-28 | $2.03 | $51K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.